Asian Oncol Nurs.  2019 Jun;19(2):71-80. 10.5388/aon.2019.19.2.71.

Factors Influencing Peripheral Neuropathy of Cancer Patients Undergoing Chemotherapy

• Yoon YJ
• Park JS

• KMID: 2451732
• DOI: http://doi.org/10.5388/aon.2019.19.2.71

Abstract

PURPOSE
We conducted a descriptive study to identify the factors affecting peripheral neuropathy in cancer patients undergoing chemotherapy.
METHODS
Data were collected from 131 cancer patients who underwent chemotherapy at two university hospitals in D city from January to July in 2018. The instruments used were the European Organization for Research and Treatment of Cancer-Chemotherapy Induced Peripheral Neuropathy 20 (EORTC-QLQ CIPN 20), International Physical Activity Questionnaire (IPAQ), nutrition and eating habits, and Hospital Anxiety & Depression Scale (HADS).
RESULTS
Factors influencing peripheral neuropathy in cancer patients undergoing chemotherapy were gender (β=−0.34, p=.005), basal cold hypersensitivity in the hands and feet (β=0.29, p<.001), depression (β=0.27, p=.002), and diabetes (β=0.23, p<.001). The explanatory power of the model was 41.1%.
CONCLUSION
Based on the results of the study, it is necessary to plan nursing interventions for cancer patients undergoing chemotherapy with peripheral neuropathy by considering gender, cold hypersensitivity in the hands and feet, depression, and diabetes.

Keyword

Chemotherapy; Peripheral neuropathy; Cancer

MeSH Terms

Anxiety
Depression
Drug Therapy*
Eating
Foot
Hand
Hospitals, University
Humans
Hypersensitivity
Motor Activity
Nursing
Peripheral Nervous System Diseases*

Reference

1. National Cancer Information Center(KR). Statistics of cancer [Internet]. Available from. http://www.cancer.go.kr/mbs/cancer/index.jsp. [Accessed October 9, 2018].

2. Lee SY, Ham YH, Ok ON, Kim EJ, Kwon IG, Hwang MS, et al. The effects of foot reflexology on peripheral neuropathy, symptom distress, anxiety and depression in cancer patients treated with oxaliplatin. Asian Oncol Nurs. 2012; 12(4):305–13.

3. Tofthagen CS, McMillan SC, Kip KE. Development and psychometric evaluation of the chemotherapy-induced peripheral neuropathy assessment tool. Cancer Nurs. 2011; 34(4):E10–20.

4. Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neuropathy. J Neurol. 2002; 249(1):9-17.

5. Miltenburg N, Boogerd W. Chemotherapy-induced neuropathy: a comprehensive survey. Cancer Treat Rev. 2014; 40(7):872–82.

6. Kwak MK, Kim EJ, Lee ER, Kwon IG, Hwang MS. Characteristics and quality of life in patients with chemotherapy-Induced peripheral neuropathy. Asian Oncol Nurs. 2010; 10(2):231–9.

7. Bao T, Basal C, Seluzicki C, Li SQ, Seidman AD, Mao JJ. Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk. Breast Cancer Res Treat. 2016; 159(2):327–33.

8. Boehmke MM, Dickerson SS. Symptom, symptom experiences, and symptom distress encountered by women with breast cancer undergoing current treatment modalities. Cancer Nurs. 2005; 28(5):382–9.

9. Grisold W, Cavaletti G, Windebank AJ. Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and pre-vention. Neuro Oncol. 2012; 14(4):45–54.

10. Vincenzi B, Frezza AM, Schiavon G, Spoto C, Addeo R, Catalano V, et al. Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV. Support Care Cancer. 2013; 21:1313–9.

11. Han JW. A study on type of chemotherapy-induced peripheral neuropathy symptom, influencing factors, and functional status. [master's thesis]. Seoul: Kyung Hee Univ.;2014.

12. Pereira S, Fontes F, Sonin T, Dias T, Fragoso M, Castro-Lopes J, et al. Chemotherapy-induced peripheral neuropathy after neoadjuvant or adjuvant treatment of breast cancer: a prospective cohort study. Support Care Cancer. 2016; 24(4):1571–81.

13. Reyes-Gibby CC, Morrow PK, Buzdar A, Shete S. Chemotherapy-induced peripheral neuropathy as a predictor of neuropathic pain in breast cancer patients previously treated with paclitaxel. J Pain. 2009; 10(11):1146–50.

14. Hershman DL, Weimer LH, Wang A, Kranwinkel G, Brafman L, Fuen-tes D, et al. Association between patient reported outcomes and quan-titative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy. Breast Cancer Res Treat. 2011; 125(3):767–74.

15. Greenlee H, Hershman DL, Shi Z, Kwan ML, Ergas IJ, Roh JM, et al. BMI, lifestyle factors and taxane-induced neuropathy in breast cancer patients: The pathways study. J Natl Cancer Inst. 2017; 109(2):1–8.

16. Derksen TM, Bours MJ, Mols F, Weijenberg MP. Lifestyle-related factors in the self-management of chemotherapy-induced peripheral neuropathy in colorectal cancer: a systemic review. Evid Based Complement Alternat Med. 2017; 1–14.

17. Han SS, Han SS, Han JW. The influences of depression, anxiety, social support and knowledge of anticancer drugs on the chemotherapy-induced peripheral neuropathy among colorectal cancer patients receiving oxaliplatin. Evid Based Complement Alternat Med. 2013; 19(2):298–308.

18. Jang JB, Lee KS, Song BK. Study on the definition of the female's part-coldness syndrome. J Korean Med. 1994; 15(2):397–411.

19. Park SO. Dietary and socioeconomic factors that influence on the in-take of B vitamins in pregnant women [master's thesis]. Seoul: Ewha Womans Univ.;2003.

20. Choi JI. A study on diet and nutritional status of breast cancer patient [master's thesis]. Seoul: Ewha Womans Univ.;2005.

21. Tofthagen C, Gonzlez L, Visovsky C, Akers A. Self-management of ox-aliplatin-related peripheral neuropathy in colorectal cancer survivors. Chemother Res Pract. 2013; 2013(1):1-7.

22. Oh JY, Yang YJ, Kim BS, Kang JH. Validity and reliability of Korean version of International Physical Activity Questionnaire (IPAQ) Short Form. J Korean Acad Fam Med. 2007; 28:532–41.

23. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67(6):361–70.

24. Oh SM, Min KJ, Park DB. A study on the standardization of the Hospital Anxiety Depression Scale for Koreans: a comparison of normal, de-pressed and anxious groups. J Korean Neuropsychiatr Assoc. 1999; 38(2):289–96.

25. Kim HM. Symptoms and relief therapy related to chemotherapy induced peripheral neuropathy in patients with cancer [master's thesis]. Daegu: Keimyung Univ.;2012.

26. Park YR. The relationships among the degree of peripheral neuropathy, a sense of control and the quality of life in cancer patients receiving chemotherapy [master's thesis]. Seoul: Dankook Univ.;2014.

27. Goveas JS, Espeland MA, Woods NF, Wassertheil-Smoller S, Kotchen JM. Depressive symptoms and incidence of mild cognitive impairment and probable dementia in elderly women: the women's health initiative memory study. J Am Geriatr Soc. 2011; 59(1):57–66.

28. Altaf R, Brixen AL, Kristensen B, Nielsen SE. Incidence of cold-induced peripheral neuropathy and dose modification of adjuvant oxaliplatin-based chemotherapy for patients with colorectal cancer. Oncology. 2014; 87(3):167–72.

29. Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017; 40(1):136–54.